Research · Sep 3, 2026
HR Healthcare Realty Trust Thesis 2026: Medical Outpatient Building REIT Drives On Campus Occupancy Recovery Capital Return
Healthcare Realty Trust Incorporated (NYSE: HR) FY2026 thesis centers on continued On-Campus Medical Outpatient Building Occupancy Recovery pipeline (~650+ aggregate medical outpatient buildings MOBs + ~38-40M aggregate square feet) + Portfolio Optimization + Capital Recycling + Development pipeline under continued President + CEO Peter Scott since 2024 (~1-2 year tenure as Healthcare Realty Trust CEO; selected post-2024 succession from Todd Meredith departure + selected post-2024 succession from Physicians Realty Trust CFO / Welltower executive background + selected primary architect of post-2024 strategic reset toward occupancy recovery + portfolio optimization + post-2022 ~$18B aggregate Healthcare Trust of America merger integration + post-2024 non-core asset disposition + leverage reduction). FY2025 revenue ~$1.25-1.40B (-3 to +3% YoY) with adj. FFO/share ~$1.55-1.75 reflecting continued ~$11.5-12.5B aggregate gross real estate assets + ~88-92% aggregate occupancy + ~3-4% aggregate same-store NOI growth. HR operates as 1 primary segment (medical outpatient building REIT) with geographic mix major MSA concentration — Dallas + Houston + Atlanta + Charlotte + Seattle + Denver + Nashville + Sun Belt + growth markets across ~35+ states. On-Campus Medical Outpatient Building Occupancy Recovery pipeline (~650+ MOBs; ~38-40M SF): selected primary ~70%+ aggregate on-campus or adjacent-to-hospital concentration (differentiated vs off-campus MOB peers + ~higher tenant retention + ~higher rent escalators) + ~88-92% aggregate occupancy (post-2022 Healthcare Trust of America merger occupancy dilution + ~+100-300bps aggregate occupancy recovery trajectory toward ~92-94% stabilized occupancy) + ~3-4% aggregate same-store cash NOI growth + ~3-4% aggregate annual rent escalators + health system + physician group + ~60%+ aggregate investment-grade or credit-rated tenant base + ~$1B+ aggregate developer/operator multi-tenant property management platform + major MSA concentration. Portfolio Optimization + Capital Recycling + Development pipeline (Strategic Catalyst): selected primary post-2024 non-core asset disposition + capital recycling (~$0.5-1.5B aggregate FY2024-2025 dispositions + non-core/lower-occupancy MOB sales + joint venture monetization) + development + redevelopment pipeline (~$0.1-0.3B aggregate development + redevelopment pipeline + build-to-suit + ~6.5-7.5% aggregate development yield) + ~excess capital deployment (post-2024 leverage reduction + ~$0+ aggregate buyback + dividend coverage improvement + potential ~FY2026-FY2027 acquisition resumption) + post-2024-2025 dividend coverage improvement (post-2024 dividend cut from ~$1.24 → ~$1.16 + ~AFFO payout ratio normalization toward ~75-85%). Capital position + balance sheet: ~$1.16 aggregate annual dividend (~75-90% aggregate AFFO payout ratio; ~6.0-8.0% aggregate dividend yield; post-2024 dividend cut from ~$1.24 → ~$1.16 + dividend coverage improvement trajectory) + no aggregate FY2025 buybacks (capital reinvestment + leverage reduction priority) + aggregate capital return ~$415-420M FY2025 + net leverage ~6.0-6.5x Net Debt/EBITDA (post-2022 Healthcare Trust of America merger elevated leverage + post-2024-2025 deleveraging glide path toward ~5.5-6.0x) + investment-grade Baa2/BBB credit rating + ~355-365M aggregate diluted shares + OP units. FY2026 base case ~$1.27-1.42B aggregate revenue + ~$1.55-1.80 adj. FFO/share + ~$415-425M aggregate capital return; bull case On-Campus Medical Outpatient Building Occupancy Recovery pipeline acceleration (~89-93% occupancy recovery toward ~92-94% stabilized + ~3-4% same-store cash NOI growth + ~3-4% annual rent escalators + ~70%+ on-campus or adjacent-to-hospital concentration + health system outpatient migration + ambulatory care demand tailwind + Federal Reserve interest rate cut cap rate compression) + Portfolio Optimization + Capital Recycling + Development pipeline acceleration (~$0.3-1.0B FY2026 dispositions + ~$0.1-0.3B development pipeline + leverage reduction toward ~5.5-6.0x + dividend coverage improvement + potential acquisition resumption) drives ~$1.35-1.50B aggregate revenue + ~$1.75-2.00 adj. FFO/share; bear case Welltower + Ventas + Healthpeak Properties + Omega Healthcare + Medical Properties Trust + Global Medical REIT + Sila Realty + American Healthcare REIT + Community Healthcare Trust competitive intensification + medical office building leasing cycle considerations + health system + physician group tenant credit considerations + Federal Reserve interest rate cycle considerations (cap rate sensitivity + cost of capital) + occupancy recovery execution considerations + post-2022 Healthcare Trust of America merger integration considerations + ambulatory care demand cycle considerations + post-2024-2025 deleveraging glide path execution considerations + dividend coverage improvement execution considerations + post-2024 Peter Scott CEO succession planning considerations drives ~$1.20-1.30B revenue + ~$1.40-1.55 adj. FFO/share.